Table 1.

Disease and patient characteristics of thyroid specimens used in this study

No	Tumour stage	Patient age range (years)	Tissue received
1	T2NXMX	40–50	M
2	T4aN1bMX	40–50	M
3	T3aNXMX	40–50	M
4	BG	50–60	B
5	T2NXMX	50–60	M,B
6	T3N1bMX	20–30	M
7	T4N0M0	80–90	M
8	T1aNXMX	60–70	M
9	BG	60–70	B
10	T2N1BMX	30–40	M,B
11	T3N1aMX	50–60	M
12	BG	30–40	B
13	BG	50–60	B
14	T4N0M1	50–60	M
15	T1aN1bMX	40–50	M
16	T1bNXMX	40–50	M,B
17	T3aNXMX	10–20	M
18	T3bN1aMX	40–50	M,B
19	T1NXMX	60–70	M,B
20	T1aNXMX	10–20	M
21	T3AN1bMX	30–40	M,B
22	T3aN1bM0	20–30	M
23	T1aNXMX	40–50	M,B
24	T3N1bM0	30–40	M,B
25	T2NXMX	70–80	M,B
26	T3aNXMX	60–70	M
27	T4aN1bMX	70–80	M,B

BG Benign goitre, M Malignant tissue, B Benign tissue